Reproductive and metabolic phenotype of a mouse model of PCOS.

Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women in their reproductive age, is characterized by both reproductive and metabolic features. Recent studies in human, nonhuman primates, and sheep suggest that hyperandrogenism plays an important role in the development of PCOS. We investigated whether chronic dihydrotestosterone (DHT) exposure in mice reproduces both features of PCOS. Such a model would allow us to study the mechanism of association between the reproductive and metabolic features in transgenic mice. In this study, prepubertal female mice received a 90 d continuous release pellet containing the nonaromatizable androgen DHT or vehicle. At the end of the treatment period, DHT-treated mice were in continuous anestrous, their ovaries contained an increased number of atretic follicles, with the majority of atretic antral follicles having a cyst-like structure. Chronic DHT-exposed mice had significantly higher body weights (21%) than vehicle-treated mice. In addition, fat depots of DHT-treated mice displayed an increased number of enlarged adipocytes (P < 0.003). Leptin levels were elevated (P < 0.013), adiponectin levels were diminished (P < 0.001), and DHT-treated mice were glucose intolerant (P < 0.001). In conclusion, a mouse model of PCOS has been developed showing reproductive and metabolic characteristics associated with PCOS in women.

[1]  M. Buysschaert,et al.  Definition of prediabetes. , 2011, The Medical clinics of North America.

[2]  R. Swerdloff,et al.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometry , 2011, Steroids.

[3]  S. Bhasin,et al.  Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. , 2009, The Journal of clinical endocrinology and metabolism.

[4]  D. Abbott,et al.  Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys , 2009, American journal of primatology.

[5]  D. Goulis,et al.  Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. , 2009, Human reproduction update.

[6]  Almudena Veiga-Lopez,et al.  Developmental Programming: Differential Effects of Prenatal Testosterone and Dihydrotestosterone on Follicular Recruitment, Depletion of Follicular Reserve, and Ovarian Morphology in Sheep1 , 2009, Biology of reproduction.

[7]  S. Pençe,et al.  The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism , 2009, Archives of Gynecology and Obstetrics.

[8]  F. Visseren,et al.  Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. , 2008, European heart journal.

[9]  H. F. E. Morreale.  Polycystic ovary syndrome: treatment strategies and management , 2008 .

[10]  A. Dunaif,et al.  Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. , 2008, American journal of physiology. Endocrinology and metabolism.

[11]  E. Stener-Victorin,et al.  A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. , 2007, Endocrinology.

[12]  V. Padmanabhan,et al.  Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. , 2007, Endocrinology.

[13]  A. Uitterlinden,et al.  Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. , 2007, Human reproduction.

[14]  D. Dewailly,et al.  Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  J. Visser,et al.  Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. , 2006, Endocrinology.

[16]  D. Dewailly,et al.  Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  M. McCarthy,et al.  Obesity and polycystic ovary syndrome , 2006, Clinical endocrinology.

[18]  E. Codner,et al.  Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. , 2005, American journal of physiology. Endocrinology and metabolism.

[19]  J. Stark,et al.  Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. , 2005, The Journal of clinical endocrinology and metabolism.

[20]  Kok Weng Chan,et al.  Testosterone Selectively Reduces the High Molecular Weight Form of Adiponectin by Inhibiting Its Secretion from Adipocytes* , 2005, Journal of Biological Chemistry.

[21]  B. Kos-Kudła,et al.  Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters , 2004, Journal of endocrinological investigation.

[22]  S. Moenter,et al.  Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Fauser,et al.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. , 2004, Molecular human reproduction.

[24]  A. Zeleznik,et al.  Administration of dihydrotestosterone to rhesus monkeys inhibits gonadotropin-stimulated ovarian steroidogenesis. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  K. Menon,et al.  Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. , 2002, Endocrinology.

[26]  U. Pagotto,et al.  Obesity and the polycystic ovary syndrome , 2002, International Journal of Obesity.

[27]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[28]  A. Wallace,et al.  Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. , 2001, European journal of endocrinology.

[29]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[30]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .

[31]  S Fiorini,et al.  Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. , 2000, The Journal of clinical endocrinology and metabolism.

[32]  R. Legro.  The Genetics of Obesity Lessons for Polycystic Ovary Syndrome , 2000, Annals of the New York Academy of Sciences.

[33]  Jane E. Robinson,et al.  In Utero Exposure of Female Lambs to Testosterone Reduces the Sensitivity of the GnRH Neuronal Network to Inhibition by Progesterone. , 1999, Endocrinology.

[34]  C. Bondy,et al.  Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. , 1999, Human reproduction.

[35]  C. Bondy,et al.  Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. , 1999, The Journal of clinical endocrinology and metabolism.

[36]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[37]  S. Franks,et al.  Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  H. Mason,et al.  Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. , 1998, The Journal of clinical endocrinology and metabolism.

[39]  S. Agarwal,et al.  A mechanism for the suppression of estrogen production in polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[40]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[41]  V. Mahesh,et al.  Effect of dihydrotestosterone on the growth and function of ovarian follicles in intact immature female rats primed with PMSG. , 1990, Journal of reproduction and fertility.

[42]  S. Hillier,et al.  Alterations in granulosa cell aromatase activity accompanying preovulatory follicular development in the rat ovary with evidence that 5alpha-reduced C19 steroids inhibit the aromatase reaction in vitro. , 1980, The Journal of endocrinology.

[43]  S. Hillier,et al.  Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. , 1979, Biology of reproduction.

[44]  J. Timmons,et al.  Recruited vs. nonrecruited molecular signatures of brown, "brite," and white adipose tissues. , 2012, American journal of physiology. Endocrinology and metabolism.

[45]  Y. Matsuzawa.  Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.

[46]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[47]  B. Fauser,et al.  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. , 2004, The Journal of clinical endocrinology and metabolism.

[48]  D. Abbott,et al.  Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. , 1997, Fertility and sterility.

[49]  H. Uchino,et al.  DEPARTMENT OF INTERNAL MEDICINE , 1966 .

[50]  R. Gorski,et al.  Evidence that the hypothalamus is responsible for androgen-induced sterility in the female rat. , 1961, Endocrinology.